Cargando…
Bleomycin Concentration in Patients’ Plasma and Tumors after Electrochemotherapy. A Study from InspECT Group
The plasma concentration profile of bleomycin in the distribution phase of patients younger than 65 years is needed to determine the suitable time interval for efficient application of electric pulses during electrochemotherapy. Additionally, bleomycin concentrations in the treated tumors for effect...
Autores principales: | Groselj, Ales, Bosnjak, Masa, Krzan, Mojca, Kosjek, Tina, Bottyán, Kriszta, Plesnik, Helena, Jamsek, Crt, Cemazar, Maja, Kis, Erika, Sersa, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469090/ https://www.ncbi.nlm.nih.gov/pubmed/34575400 http://dx.doi.org/10.3390/pharmaceutics13091324 |
Ejemplares similares
-
Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report
por: Muir, Tobian, et al.
Publicado: (2023) -
Long Term Response of Electrochemotherapy with Reduced Dose of Bleomycin in Elderly Patients with Head and Neck Non-melanoma Skin Cancer
por: Jamsek, Crt, et al.
Publicado: (2020) -
Combination of Pembrolizumab with Electrochemotherapy in Cutaneous Metastases from Melanoma: A Comparative Retrospective Study from the InspECT and Slovenian Cancer Registry
por: Campana, Luca G., et al.
Publicado: (2021) -
Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019)
por: Bertino, Giulia, et al.
Publicado: (2022) -
An effective validation of analytical method for determination of a polar complexing agent: the illustrative case of cytotoxic bleomycin
por: Plesnik, Helena, et al.
Publicado: (2023)